Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches

Journal of the American Academy of Dermatology

Volumn 50, Issue 1, 2004, Pages 63-67

  Parsad, Davinder ^a,b   Pandhi, Roma ^a,b   Dogra, Sunil ^a,b   Kumar, Bhushan ^a,b  

^a Postgrad Inst of Med Educ/Res ^*

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CLOBETASOL PROPIONATE; CORTICOSTEROID; DEXAMETHASONE; PSORALEN; STEROID;

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUVA; SKIN PIGMENTATION; SKIN REPIGMENTATION; STEROID THERAPY; TREATMENT OUTCOME; VITILIGO;

EID: 0347634492     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(03)00786-2     Document Type: Article

References (14)

1. Ortonne JP, Schmitt D, Thivolet J. PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. J Invest Dermatol 1980;74:40-2.
2. Cui J, Shen LY, Wang GC. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 1991;97:410-6.
3. Nordlund JJ, Ortonne JP. Vitiligo vulgaris. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP, editors. The pigmentary system: physiology and pathophysiology. New York: Oxford University Press; 1998. p. 513-51.
4. Ortonne J, Macdonald D, Micoud A, Thivolet J. PUVA induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study. Br J Dermatol 1979;101:1-12.
5. Kenny JA Jr. Vitiligo treated by psoralens: a long term follow up study of the permanancy of repigmentation. Arch Dermatol 1971;103:475-80.
6. Arrunategui A, Arroyo C, Garcia L, Covelli C, Carrascal E, Falabella R. Melanocyte reservoir in vitiligo. Int J Dermatol 1994; 33:484-7.
7. 14C(U)-l-tyrosine incorporation into melanin. J Invest Dermatol 1982;78:243-52.
8. Tobin DJ, Swanson NN, Pittelkow MR, Peters EM, Schallreuter KU. Melanocytes are not absent in lesional skin of long duration vitiligo. J Pathol 2000;191:407-16.
9. Bartosik J, Wulf HC, Kobayasi T. Melanin and melanosome complexes in long standing stable vitiligo-an ultra structural study. Eur J Dermatol 1998;8:95-7.
10. Jarrett A, Szabo G. The pathological varieties of vitiligo and their response to treatment with meladinine. Br J Dermatol 1956;68:313-7.
11. Cui J. The melanocyte reservoir and its necessity. In: Vitiligo A, editor. Monograph on the basic and clinical science. 1st ed. New York: Blackwell Science; p. 163-7.
12. Parsad D, Sainf R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology 1998;197:167-70.
13. Parsad D, Saini R, Nagpal R. Calcipotriol in vitiligo: a preliminary study. Pediatr Dermatol 1999;6:317-20.
14. Kandil E. Vitiligo response to 0.2% betamethasone 17-valerate in flexible colloidon. Dermatologica 1970;141:277-8.